Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 1184 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Baumgarten H, Jenks CM, Isaza A, et al. "Bilateral papillary thyroid cancer in children: Risk factors and frequency of postoperative diagnosis." J. Pediatr. Surg.. 2020.
Handley SC, Passarella M, Herrick HM, et al. "Birth Volume and Geographic Distribution of US Hospitals With Obstetric Services From 2010 to 2018." JAMA Netw Open. 2021;4(10):e2125373.
Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, et al. "Bone and Joint Infections." Pediatr. Infect. Dis. J.. 2017;36(8):788-799.
Kusumi K, Schwaderer AL, Clark C, et al. "Bone mineral density in adolescent urinary stone formers: is sex important?" Urolithiasis. 2020;48(4):329-335.
van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM, et al. "Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group." Lancet Diabetes Endocrinol. 2021.
van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM, et al. "Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group." Lancet Diabetes Endocrinol. 2021.
van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM, et al. "Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group." Lancet Diabetes Endocrinol. 2021.
van Dijk AD, Hoff FW, Qiu Y, et al. "Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA." Proteomics Clin Appl. 2021:e2100072.
van Dijk AD, Hoff FW, Qiu Y, et al. "Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA." Proteomics Clin Appl. 2021:e2100072.
Aplenc R, Meshinchi S, Sung L, et al. "Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group." Haematologica. 2020.
Aplenc R, Meshinchi S, Sung L, et al. "Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group." Haematologica. 2020.
Kimberlin DW, Puopolo KM. "Breastmilk and COVID-19: What Do We Know?" Clin. Infect. Dis.. 2020.
Elgarten CW, Li Y, Getz KD, et al. "Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD." Transplant Cell Ther. 2021;27(2):177.e1-177.e8.
Elgarten CW, Li Y, Getz KD, et al. "Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD." Transplant Cell Ther. 2021;27(2):177.e1-177.e8.
Keir A, Bamat N, Hennebry B, et al. "Building a community of practice through social media using the hashtag #neoEBM." PLoS One. 2021;16(5):e0252472.
Keir A, Bamat N, Hennebry B, et al. "Building a community of practice through social media using the hashtag #neoEBM." PLoS One. 2021;16(5):e0252472.
Krass P, Vasan A, Kenyon CC. "Building Political Capital: Engaging Families in Child Health Policy." Pediatrics. 2020.
Krass P, Vasan A, Kenyon CC. "Building Political Capital: Engaging Families in Child Health Policy." Pediatrics. 2020.

Pages